• MeiraGTx posted a net loss of USD 46.31 million for quarter ended March 31, 2026, widening from USD 39.98 million a year earlier.
• Revenue fell to USD 293,000 from USD 1.93 million, reflecting lower activity for process performance qualification services under the terminated Janssen asset purchase arrangements.
• Operating loss narrowed to USD 40.82 million from USD 41.6 million as total operating expenses edged down to USD 41.11 million from USD 43.52 million.
• Cash, cash equivalents, restricted cash totaled USD 73.8 million at March 31, 2026; management said funding runway extends into second half of 2028, including planned USD 25 million payment to reacquire bota-vec and scheduled Perceptive repayments of USD 25 million due June 2026 and USD 50 million due July 2027.
• April updates included reacquisition of bota-vec rights from Janssen for USD 25 million upfront, initial closing of Hologen collaboration, and a USD 100 million underwritten equity offering priced at USD 9 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-060739), on May 14, 2026, and is solely responsible for the information contained therein.